2. Mejía-Barrera MA, Martínez-Torres EE, Juárez-Figueroa U, Torres L, Fiesco-Roa MO, García-de-Teresa B, Gomez-Verjan JC, Meléndez-Zajgla J, Rodríguez A, Sánchez S et al: The tight bond between Fanconi anemia and aging. Front Aging 2026, 7. [PubMed]
3. Curiel-Gomez E, Romero-Rodriguez DP, Rodriguez-Dorantes M, Maldonado V, Melendez-Zajgla J: Pancreatic Cancer Stem Cells Co-Expressing SOX2, OCT4, and TERT Represent an Aggressive Subpopulation. Cells 2026, 15(2). [PubMed]
4. Jiménez-Hernández E, Flores-Lujano J, Medina-Sansón A, Dorantes-Acosta EM, Espinoza-Hernández LE, Amador-Sanchez R, Peñaloza-Gonzalez JG, Valdez-Garibay B, Torres-Nava JR, Espinosa-Elizondo RM et al: Undernutrition or obesity: relationship with long-term survival in children with acute lymphoblastic leukemia in an upper-middle income country: a multicenter cohort study. Am J Clin Nutr 2025, 123(2). [PubMed]
5. Gonzalez-Ruiz J, Sarmiento-Casas M, Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Vazquez-Santillan K, Maldonado V, Melendez-Zajgla J: Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma. Int J Mol Sci 2025, 26(22). [PubMed]
6. Mishal R, Melendez-Zajgla J, Rueda-Zarazúa B, Labra-Barrios ML, Castañón-Sánchez CA, Uribe Carvajal S, Padierna-Mota L, Hernández-Hernández JM, Leon-Avila G, Pérez Rangel A et al: RNA-seq analysis of wild-type and mutated TBPL1 gene in breast cancer cells lines through CRISPR/Cas9 approach reveals novel molecular signatures. Sci Rep 2025, 15(1):37578. [PubMed]
7. Fong-López AA, Núñez-Enríquez JC, Bekker-Méndez VC, Flores-Lujano J, Mata-Rocha M, Jiménez-Hernández E, Ortíz-Maganda MP, Guerra-Castillo FX, Medina-Sanson A, Martín-Trejo JA et al: Comprehensive Epigenome-Wide Profiling Reveals Distinctive DNA Methylation Signatures and Potential Prognostic Biomarkers in Mexican Pediatric B-ALL. Int J Mol Sci 2025, 26(21). [PubMed]
8. Correa-Correa V, Núñez-Enríquez JC, Mezei G, Rivera-Luna R, Peñaloza-González JG, Rivas-Carrillo SD, Ortiz-Mejía CG, Flores-Robles C, Velasco-Ramírez E, Alexis Del Real-Gallegos M et al: Extremely low-frequency magnetic fields (ELF-MF) and radiofrequency: Risk of childhood CNS tumors in a city with elevated ELF-MF exposure. Environ Res 2025, 286(Pt 2). [PubMed]
9. Sánchez-Herrera J, Valenzuela-Vázquez L, Nuñez-Enriquez JC, Arellano-Juvera F, Jiménez-Hernandéz E, Mata-Rocha M, Flores-Lujano J, Peñaloza-Gonzalez JG, Galván-Díaz CA, Torres-Nava JR et al: Influence of SLAM Family Receptors in the NK-Cell-Mediated Surveillance of Lymphoblastic Acute Leukemia. Eur J Immunol 2025, 55(8):e70014. [PubMed]
10. Melendez-Zajgla J, Camacho-Arroyo I, Ramirez MAV, Rodriguez-Dorantes M: Editorial: Advancing Molecular Oncology in Mexico. Int J Mol Sci 2025, 26(12). [PubMed]
11. Rueda-Zarazua B, Gutiérrez H, García-Ortiz H, Orozco L, Ramírez-Martínez G, Jiménez-Alvarez L, Bolaños-Morales FV, Zuñiga J, Ávila-Moreno F, Melendez-Zajgla J: A Pilot Study: Contrasting Genomic Profiles of Lung Adenocarcinoma Between Patients of European and Latin American Ancestry. Int J Mol Sci 2025, 26(10). [PubMed]
12. Sepúlveda-Robles O, Flores-Lujano J, Núñez-Enríquez JC, Jiménez-Hernández E, Duarte-Rodríguez DA, Martín-Trejo JA, Espinoza-Hernández LE, García-Jiménez X, Paredes-Aguilera R, Dosta-Herrera JJ et al: Early Infection Incidence and Risk of Acute Leukemia Development Among Mexican Children. Cancers (Basel) 2025, 17(5). [PubMed]
13. Ordaz-Ramos A, Diaz-Blancas J, Martínez-Cruz A, Castro-Oropeza R, Zampedri C, Romero-Rodríguez DP, Rodriguez-Dorantes M, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K: RANKL regulates differentially breast cancer stem cell properties through its RANK and LGR4 receptors. Biochim Biophys Acta Mol Cell Res 2024, 1872(2):119888. [PubMed]
14. Espinosa M, Herrera I, Buendía-Roldán I, Melendez-Zajgla J, Pardo A, Selman M: Determination of loss of chromosome Y in peripheral blood cells in males with idiopathic pulmonary fibrosis. Eur Respir J 2024, 64(5). [PubMed]
15. Villagómez-Olea G, Uribe-Querol E, Marichi-Rodríguez FJ, Melendez-Zajgla J, Alvaréz-Pérez MA, Rosales C: Periodontal ligament tissues support neutrophil differentiation and maturation processes. Front Immunol 2024, 15:1446541. [PubMed]
16. Limones-Gonzalez JE, Aguilar Esquivel P, Vazquez-Santillan K, Castro-Oropeza R, Lizarraga F, Maldonado V, Melendez-Zajgla J, Piña-Sanchez P, Mendoza-Almanza G: Changes in the molecular nodes of the Notch and NRF2 pathways in cervical cancer tissues from the precursor stages to invasive carcinoma. Oncol Lett 2024, 28(5):522. [PubMed]
17. Sanchez-Lopez JM, Juarez-Mancera MA, Bustamante B, Ruiz-Silvestre A, Espinosa M, Mendoza-Almanza G, Ceballos-Cancino G, Melendez-Zajgla J, Maldonado V, Lizarraga F: Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses. RNA Biol 2024, 21(1):1-11. [PubMed]
18. Ruiz-Silvestre A, Garcia-Venzor A, Ceballos-Cancino G, Sánchez-López JM, Vazquez-Santillan K, Mendoza-Almanza G, Lizarraga F, Melendez-Zajgla J, Maldonado V: Transcriptomic Changes in Cisplatin-Resistant MCF-7 Cells. Int J Mol Sci 2024, 25(7). [PubMed]
19. Duarte-Rodríguez DA, Flores-Lujano J, McNally RJQ, Pérez-Saldivar ML, Jiménez-Hernández E, Martín-Trejo JA, Espinoza-Hernández LE, Medina-Sanson A, Paredes-Aguilera R, Merino-Pasaye LE et al: Evidence of spatial clustering of childhood acute lymphoblastic leukemia cases in Greater Mexico City: report from the Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia. Front Oncol 2024, 14:1304633. [PubMed]
20. Alonso-Luna O, Mercado-Celis GE, Melendez-Zajgla J, Barquera R, Zapata-Tarres M, Juárez-Villegas LE, Mendoza-Caamal EC, Rey-Helo E, Borges-Yañez SA: Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans. Mol Genet Genomic Med 2023, 12(1):e2332. [PubMed]
21. Islam F, Melendez-Zajgla J: Editorial: Advances in genetics and molecular diagnosis in colorectal cancer. Front Oncol 2023, 13:1279195. [PubMed]
22. Skantharajah N, Baichoo S, Boughtwood TF, Casas-Silva E, Chandrasekharan S, Dave SM, Fakhro KA, Falcon de Vargas AB, Gayle SS, Gupta VK et al: Equity, diversity, and inclusion at the Global Alliance for Genomics and Health. Cell Genom 2023, 3(10):100386. [PubMed]
23. Galindo-Vega A, Maldonado-Lagunas V, Mitre-Aguilar IB, Melendez-Zajgla J: Tumor Microenvironment Role in Pancreatic Cancer Stem Cells. Cells 2023, 12(12). [PubMed]
24. Burciaga-Hernandez LA, Cueto-Villalobos CF, Ortega-Piñon N, Gonzalez-Curiel IE, Godina-Gonzalez S, Mendez-Frausto G, Aguilar-Esquivel AP, Maldonado-Lagunas V, Guerrero-de la Torre LE, Melendez-Zajgla J et al: Gene Expression Behavior of a Set of Genes in Platelet and Tissue Samples from Patients with Breast Cancer. Int J Mol Sci 2023, 24(9). [PubMed]
25. Alonso-Luna O, Mercado-Celis GE, Melendez-Zajgla J, Zapata-Tarres M, Mendoza-Caamal E: The genetic era of childhood cancer: Identification of high-risk patients and germline sequencing approaches. Ann Hum Genet 2023, 87(3):81-90. [PubMed]
26. Mitre-Aguilar IB, Moreno-Mitre D, Melendez-Zajgla J, Maldonado V, Jacobo-Herrera NJ, Ramirez-Gonzalez V, Mendoza-Almanza G: The Role of Glucocorticoids in Breast Cancer Therapy. Curr Oncol 2022, 30(1):298-314. [PubMed]
27. Díaz-Blancas JY, Dominguez-Rosado I, Chan-Nuñez C, Melendez-Zajgla J, Maldonado V: Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets. Int J Mol Sci 2022, 23(19). [PubMed]
28. Gutierrez-Cruz JA, Maldonado V, Melendez-Zajgla J: Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs. Cells 2022, 11(15). [PubMed]
29. Maldonado V, Melendez-Zajgla J: The Role of Hypoxia-Associated Long Non-Coding RNAs in Breast Cancer. Cells 2022, 11(10). [PubMed]
30. Reyes P, García-de Teresa B, Juárez U, Pérez-Villatoro F, Fiesco-Roa MO, Rodríguez A, Molina B, Villarreal-Molina MT, Meléndez-Zajgla J, Carnevale A et al: Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG. Int J Mol Sci 2022, 23(4). [PubMed]
31. De la Fuente-Hernandez MA, Sarabia-Sanchez MA, Melendez-Zajgla J, Maldonado-Lagunas V: Role of lncRNAs into Mesenchymal Stromal Cell Differentiation. Am J Physiol Cell Physiol 2022. [PubMed]
32. De la Fuente-Hernandez MA, Alanis-Manriquez EC, Ferat-Osorio E, Rodriguez-Gonzalez A, Arriaga-Pizano L, Vazquez-Santillan K, Melendez-Zajgla J, Fragoso-Ontiveros V, Alvarez-Gomez RM, Maldonado Lagunas V: Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells. Cell Oncol (Dordr) 2022. [PubMed]
33. Zampedri C, Martinez-Flores WA, Melendez-Zajgla J: The Use of Zebrafish Xenotransplant Assays to Analyze the Role of lncRNAs in Breast Cancer. Front Oncol 2021, 11:687594. [PubMed]
34. Sanchez-Lopez JM, Mandujano-Tinoco EA, Garcia-Venzor A, Lozada-Rodriguez LF, Zampedri C, Uribe-Carvajal S, Melendez-Zajgla J, Maldonado V, Lizarraga F: Integrative analysis of transcriptional profile reveals LINC00052 as a suppressor of breast cancer cell migration. Cancer Biomark 2021, 30(4):365-379. [PubMed]
35. Ordaz-Ramos A, Rosales-Gallegos VH, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K: The Role of LGR4 (GPR48) in Normal and Cancer Processes. Int J Mol Sci 2021, 22(9). [PubMed]
36. Melendez-Zajgla J, Maldonado V: The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2021, 22(12). [PubMed]
37. Garcia-Venzor A, Rueda-Zarazua B, Marquez-Garcia E, Maldonado V, Moncada-Morales A, Olivera H, Lopez I, Zuñiga J, Melendez-Zajgla J: SARS-CoV-2 Direct Detection Without RNA Isolation With Loop-Mediated Isothermal Amplification (LAMP) and CRISPR-Cas12. Front Med (Lausanne) 2021, 8:627679. [PubMed]
38. Espinosa M, Lizárraga F, Vázquez-Santillán K, Hidalgo-Miranda A, Piña-Sánchez P, Torres J, García-Ramírez RA, Maldonado V, Melendez-Zajgla J, Ceballos-Cancino G: Coexpression of Smac/DIABLO and Estrogen Receptor in breast cancer. Cancer Biomark 2021, 30(4):429-446. [PubMed]
39. Egusquiza-Alvarez CA, Castañeda-Patlán MC, Albarran-Gutierrez S, Gonzalez-Aguilar H, Moreno-Londoño AP, Maldonado V, Melendez-Zajgla J, Robles-Flores M: Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells. Front Oncol 2021, 11:642940. [PubMed]
40. Schwarz-Cruz YCA, Ceballos-Cancino G, Vazquez-Santillan K, Espinosa M, Zampedri C, Bahena I, Ruiz V, Maldonado V, Melendez-Zajgla J: Basal-Type Breast Cancer Stem Cells Over-Express Chromosomal Passenger Complex Proteins. Cells 2020, 9(3). [PubMed]
41. Sanchez P, Espinosa M, Maldonado V, Barquera R, Belem-Gabino N, Torres J, Cravioto A, Melendez-Zajgla J: Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern. Mol Biol Rep 2020, 47(7):5175-5184. [PubMed]
42. Mendoza-Almanza G, Burciaga-Hernandez L, Maldonado V, Melendez-Zajgla J, Olmos J: Role of platelets and breast cancer stem cells in metastasis. World J Stem Cells 2020, 12(11):1237-1254. [PubMed]
43. Garcia-Venzor A, Mandujano-Tinoco EA, Ruiz-Silvestre A, Sanchez JM, Lizarraga F, Zampedri C, Melendez-Zajgla J, Maldonado V: lncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells. Carcinogenesis 2020, 41(11):1485-1497. [PubMed]
44. FernAndez-Rojas MA, Melendez-Zajgla J, Lagunas VM: lincRNA-RP11400K9.4 Regulates Cell Survival and Migration of Breast Cancer Cells. Cancer Genomics Proteomics 2020, 17(6):769-779. [PubMed]
45. Dominguez-Rosado I, Melendez-Zajgla J: Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy. Rev Invest Clin 2020, 72(6):333-336. [PubMed]
46. Castro-Oropeza R, Vazquez-Santillan K, Diaz-Gastelum C, Melendez-Zajgla J, Zampedri C, Ferat-Osorio E, Rodriguez-Gonzalez A, Arriaga-Pizano L, Maldonado V: Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer. Sci Rep 2020, 10(1):14205. [PubMed]
47. Ruiz-Zamora RA, Guillaume S, Al-Hilaly YK, Al-Garawi Z, Rodriguez-Alvarez FJ, Zavala-Padilla G, Perez-Carreon JI, Rodriguez-Ambriz SL, Herrera GA, Becerril-Lujan B et al: The CDR1 and Other Regions of Immunoglobulin Light Chains are Hot Spots for Amyloid Aggregation. Sci Rep 2019, 9(1):3123. [PubMed]
48. Orlova Z, Pruefer F, Castro-Oropeza R, Ordaz-Ramos A, Zampedri C, Maldonado V, Vazquez-Santillan K, Melendez-Zajgla J: IKKepsilon regulates the breast cancer stem cell phenotype. Biochim Biophys Acta Mol Cell Res 2019, 1866(4):598-611. [PubMed]
49. Munoz-Galindo L, Melendez-Zajgla J, Pacheco-Fernandez T, Rodriguez-Sosa M, Mandujano-Tinoco EA, Vazquez-Santillan K, Castro-Oropeza R, Lizarraga F, Sanchez-Lopez JM, Maldonado V: Changes in the transcriptome profile of breast cancer cells grown as spheroids. Biochem Biophys Res Commun 2019, 516(4):1258-1264. [PubMed]
50. Garcia-Venzor A, Mandujano-Tinoco EA, Lizarraga F, Zampedri C, Krotzsch E, Salgado RM, Davila-Borja VM, Encarnacion-Guevara S, Melendez-Zajgla J, Maldonado V: Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells. Biochim Biophys Acta Mol Cell Res 2019, 1866(12):118523. [PubMed]
51. Camacho-Moctezuma B, Quevedo-Castillo M, Melendez-Zajgla J, Aquino-Jarquin G, Martinez-Ruiz GU: YY1 negatively regulates the XAF1 gene expression in prostate cancer. Biochem Biophys Res Commun 2019, 508(3):973-979. [PubMed]
52. Munguia-Reyes A, Balderas-Martinez YI, Becerril C, Checa M, Ramirez R, Ortiz B, Melendez-Zajgla J, Pardo A, Selman M: R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior. Am J Respir Cell Mol Biol 2018, 59(1):65-76. [PubMed]
53. Melendez-Zajgla J, Mercado-Celis GE, Gaytan-Cervantes J, Torres A, Gabino NB, Zapata-Tarres M, Juarez-Villegas LE, Lezama P, Maldonado V, Ruiz-Monroy K et al: Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome. Sci Rep 2018, 8(1):3252. [PubMed]
54. Mandujano-Tinoco EA, Garcia-Venzor A, Melendez-Zajgla J, Maldonado V: New emerging roles of microRNAs in breast cancer. Breast Cancer Res Treat 2018, 171(2):247-259. [PubMed]
55. Jimenez-Hernandez LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, Munoz-Galindo L, Gonzalez-Torres C, Cortes-Gonzalez CC, Victoria-Acosta G, Melendez-Zajgla J, Maldonado V: NRP1-positive lung cancer cells possess tumor-initiating properties. Oncol Rep 2018, 39(1):349-357. [PubMed]
56. Cervantes-Garduno A, Zampedri C, Espinosa M, Maldonado V, Melendez-Zajgla J, Ceballos-Cancino G: MT4-MMP Modulates the Expression of miRNAs in Breast Cancer Cells. Arch Med Res 2018, 49(7):471-478. [PubMed]
57. Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K: The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol (Dordr) 2018, 41(6):585-603. [PubMed]
58. Rodríguez-Peredo SM, Castellanos-Jankiewicz AK, Imaz-Rosshandler I, Espinoza-Camacho MA, Rangel-Escareño C, Muñoz-Sánchez JL, Melendez-Zajgla J, Tejero ME, Carbó R, Maldonado V et al: Modulation of the lung RNAome in a metabolic syndrome rat model. Int J Clin Exp Pathol 2017, 10(5):5379-5392.
59. Mandujano-Tinoco EA, Garcia-Venzor A, Munoz-Galindo L, Lizarraga-Sanchez F, Favela-Orozco A, Chavez-Gutierrez E, Krotzsch E, Salgado RM, Melendez-Zajgla J, Maldonado V: miRNA expression profile in multicellular breast cancer spheroids. Biochim Biophys Acta Mol Cell Res 2017, 1864(10):1642-1655. [PubMed]
60. Gaytan-Cervantes J, Gonzalez-Torres C, Maldonado V, Zampedri C, Ceballos-Cancino G, Melendez-Zajgla J: Protein Sam68 regulates the alternative splicing of survivin DEx3. J Biol Chem 2017, 292(33):13745-13757. [PubMed]
61. Garay Sanchez SA, Rodriguez Alvarez FJ, Zavala-Padilla G, Mejia-Cristobal LM, Cruz-Rangel A, Costas M, Fernandez Velasco DA, Melendez-Zajgla J, Del Pozo-Yauner L: Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis. Biol Chem 2017, 398(4):477-489. [PubMed]
62. Vazquez-Santillan K, Melendez-Zajgla J, Jimenez-Hernandez LE, Gaytan-Cervantes J, Munoz-Galindo L, Pina-Sanchez P, Martinez-Ruiz G, Torres J, Garcia-Lopez P, Gonzalez-Torres C et al: NF-kappaBeta-inducing kinase regulates stem cell phenotype in breast cancer. Sci Rep 2016, 6:37340. [PubMed]
63. Schwarz-Cruz YCA, Espinosa M, Maldonado V, Melendez-Zajgla J: Advances in the knowledge of breast cancer stem cells. A review. Histol Histopathol 2016, 31(6):601-612. [PubMed]
64. Pruefer F, Vazquez-Santillan K, Munoz-Galindo L, Cruz-Colin JL, Maldonado V, Melendez-Zajgla J: TIMP4 Modulates ER-alpha Signalling in MCF7 Breast Cancer Cells. Folia Biol (Praha) 2016, 62(2):75-81. [PubMed]
65. Pacheco-Marin R, Melendez-Zajgla J, Castillo-Rojas G, Mandujano-Tinoco E, Garcia-Venzor A, Uribe-Carvajal S, Cabrera-Orefice A, Gonzalez-Torres C, Gaytan-Cervantes J, Mitre-Aguilar IB et al: Transcriptome profile of the early stages of breast cancer tumoral spheroids. Sci Rep 2016, 6:23373. [PubMed]
66. Lopez-Marure R, Zapata-Gomez E, Rocha-Zavaleta L, Aguilar MC, Espinosa Castilla M, Melendez Zajgla J, Meraz-Cruz N, Huesca-Gomez C, Gamboa-Avila R, Gomez-Gonzalez EO: Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines. Cancer Biol Ther 2016, 17(9):915-924. [PubMed]
67. Lizarraga F, Espinosa M, Ceballos-Cancino G, Vazquez-Santillan K, Bahena-Ocampo I, Schwarz-Cruz YCA, Vega-Gordillo M, Garcia Lopez P, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells. Mol Carcinog 2016, 55(12):1952-1961. [PubMed]
68. Campos-Arroyo D, Maldonado V, Bahena I, Quintanar V, Patino N, Carlos Martinez-Lazcano J, Melendez-Zajgla J: Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin. Cancer Invest 2016, 34(3):155-166. [PubMed]
69. Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Garcia-Lopez P, Maldonado V, Melendez-Zajgla J: miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation. EMBO Rep 2016, 17(7):1081. [PubMed]
70. Victoria-Acosta G, Vazquez-Santillan K, Jimenez-Hernandez L, Munoz-Galindo L, Maldonado V, Martinez-Ruiz GU, Melendez-Zajgla J: Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding. Sci Rep 2015, 5:14838. [PubMed]
71. Vazquez-Santillan K, Melendez-Zajgla J, Jimenez-Hernandez L, Martinez-Ruiz G, Maldonado V: NF-kappaB signaling in cancer stem cells: a promising therapeutic target? Cell Oncol (Dordr) 2015, 38(5):327-339. [PubMed]
72. Salcido-Neyoy ME, Sanchez-Perez Y, Osornio-Vargas AR, Gonsebatt ME, Melendez-Zajgla J, Morales-Barcenas R, Petrosyan P, Molina-Servin ED, Vega E, Manzano-Leon N et al: Induction of c-Jun by air particulate matter (PM(1)(0)) of Mexico city: Participation of polycyclic aromatic hydrocarbons. Environ Pollut 2015, 203:175-182. [PubMed]
73. Morales-Barcenas R, Chirino YI, Sanchez-Perez Y, Osornio-Vargas AR, Melendez-Zajgla J, Rosas I, Garcia-Cuellar CM: Particulate matter (PM(1)(0)) induces metalloprotease activity and invasion in airway epithelial cells. Toxicol Lett 2015, 237(3):167-173. [PubMed]
74. Mejia-Cristobal LM, Reus E, Lizarraga F, Espinosa M, Ceballos-Cancino G, Lopez TV, Garay S, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteases-4 (TIMP-4) modulates adipocyte differentiation in vitro. Exp Cell Res 2015, 335(2):207-215. [PubMed]
75. Lizarraga F, Ceballos-Cancino G, Espinosa M, Vazquez-Santillan K, Maldonado V, Melendez-Zajgla J: Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells. PLoS One 2015, 10(8):e0135929. [PubMed]
76. Torres Mena JE, Sanchez Rodriguez R, Quintanar Jurado V, Mojica Espinosa R, Del Pozo Yauner L, Melendez Zajgla J, Villa Trevino S, Perez Carreon JI: Laser capture microdissection after gamma-glutamyl transferase histochemistry: an optimization for gene expression analysis. Anal Biochem 2014, 447:126-132. [PubMed]
77. Sanchez-Rodriguez R, Torres-Mena JE, De-la-Luz-Cruz M, Bernal-Ramos GA, Villa-Trevino S, Chagoya-Hazas V, Landero-Lopez L, Garcia-Roman R, Rouimi P, Del-Pozo-Yauner L et al: Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats. Int J Biochem Cell Biol 2014, 53:186-194. [PubMed]
78. Salazar-Olivo LA, Mejia-Elizondo R, Alonso-Castro AJ, Ponce-Noyola P, Maldonado-Lagunas V, Melendez-Zajgla J, Saavedra-Alanis VM: SerpinA3g participates in the antiadipogenesis and insulin-resistance induced by tumor necrosis factor-alpha in 3T3-F442A cells. Cytokine 2014, 69(2):180-188. [PubMed]
79. Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS et al: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A 2014, 111(51):E5564-5573. [PubMed]
80. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B et al: Landscape of genomic alterations in cervical carcinomas. Nature 2014, 506(7488):371-375. [PubMed]
81. Melendez-Zajgla J, Maldonado Lagunas V: Genomes of the cancer. Where do we go from here? Gaceta Medica De Mexico 2014, 150(6):563-569. [PubMed]
82. Martinez-Ruiz GU, Victoria-Acosta G, Vazquez-Santillan KI, Jimenez-Hernandez L, Munoz-Galindo L, Ceballos-Cancino G, Maldonado V, Melendez-Zajgla J: Ectopic expression of new alternative splice variant of Smac/DIABLO increases mammospheres formation. Int J Clin Exp Pathol 2014, 7(9):5515-5526. [PubMed]
83. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA et al: Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013, 499(7457):214-218. [PubMed]
84. Garcia I, Cosio G, Lizarraga F, Martinez-Ruiz G, Melendez-Zajgla J, Ceballos G, Espinosa M, Pacheco R, Maldonado V: Bcl-3 regulates UVB-induced apoptosis. Hum Cell 2013, 26(2):47-55. [PubMed]
85. Ceballos-Cancino G, Melendez-Zajgla J: DIABLO (diablo, IAP-binding mitochondrial protein). Atlas Genet Cytogenet Oncol Haematol 2013(http://AtlasGeneticsOncology.org/Genes/DIABLOID42995ch12q24.html).
86. Montes E, Ruiz V, Checa M, Maldonado V, Melendez-Zajgla J, Montano M, Ordonez-Razo R, Cisneros J, Garcia-de-Alba C, Pardo A et al: Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis. Eur Respir J 2012, 39(1):141-148. [PubMed]
87. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL et al: Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 2012, 109(10):3879-3884. [PubMed]
88. Espinosa M, Ceballos-Cancino G, Callaghan R, Maldonado V, Patino N, Ruiz V, Melendez-Zajgla J: Survivin isoform Delta Ex3 regulates tumor spheroid formation. Cancer Lett 2012, 318(1):61-67. [PubMed]
89. Campos-Arroyo D, Martinez-Lazcano JC, Melendez-Zajgla J: Probenecid is a chemosensitizer in cancer cell lines. Cancer Chemother Pharmacol 2012, 69(2):495-504. [PubMed]
90. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L et al: Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486(7403):405-409. [PubMed]
91. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A et al: The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333(6046):1157-1160. [PubMed]
92. Schwarz-Cruz-y-Celis A, Melendez-Zajgla J: Cancer stem cells. Rev Invest Clin 2011, 63(2):179-186. [PubMed]
93. Maldonado V, Melendez-Zajgla J: Role of Bcl-3 in solid tumors. Mol Cancer 2011, 10:152. [PubMed]
94. Zamora R, Espinosa M, Ceballos-Cancino G, Segura B, Maldonado V, Melendez-Zajgla J: Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells. Mol Cancer 2010, 9:223. [PubMed]
95. Soberon-Mainero X, Melendez-Zajgla J: [The Instituto Nacional de Medicina Genomica. Vocation and challenges]. Rev Invest Clin 2010, 62(5):391-392. [PubMed]
96. Munoz L, Espinosa M, Quintanar-Jurado V, Hidalgo A, Melendez-Zajgla J, Maldonado V: Paradoxial changes in the expression of estrogen receptor alpha in breast cancer multicellular spheroids. Tissue Cell 2010, 42(5):334-337. [PubMed]
97. Maldonado V, Espinosa M, Pruefer F, Patino N, Ceballos-Canciono G, Urzua U, Juretic N, Melendez-Zajgla J: Gene regulation by BCL3 in a cervical cancer cell line. Folia Biol (Praha) 2010, 56(4):183-193. [PubMed]
98. Perez-Rojas JM, Cruz C, Garcia-Lopez P, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Ceballos G, Espinosa M, Melendez-Zajgla J, Pedraza-Chaverri J: Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 2009, 43(11):1122-1132. [PubMed]
99. Melendez-Zajgla J: Personalized medicine. So close and so far away. Revista De Investigacion Clinica-Clinical and Translational Investigation 2009, 61(6):454-455. [PubMed]
100. Gallardo-Perez JC, Espinosa M, Ceballos-Cancino G, Daniel A, Rodriguez-Enriquez S, Aviles A, Moreno-Sanchez R, Melendez-Zajgla J, Maldonado V: NF-kappa B is required for the development of tumor spheroids. J Cell Biochem 2009, 108(1):169-180. [PubMed]
101. Pruefer FG, Lizarraga F, Maldonado V, Melendez-Zajgla J: Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J Chemother 2008, 20(3):348-354. [PubMed]
102. Meléndez-Zajgla J, G C-C: Sobreviviendo a diablo: lecciones de la survivina en la apoptosis Mensaje Bioquímico 2008, 32:175-184.
103. Melendez-Zajgla J, Del Pozo L, Ceballos G, Maldonado V: Tissue inhibitor of metalloproteinases-4. The road less traveled. Mol Cancer 2008, 7:85. [PubMed]
104. Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J: Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res 2008, 27:48. [PubMed]
105. Lagunas VM, Melendez-Zajgla J: Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs. Met Based Drugs 2008, 2008:576104. [PubMed]
106. Ramirez-Ortega M, Zarco G, Maldonado V, Carrillo JF, Ramos P, Ceballos G, Melendez-Zajgla J, Garcia N, Zazueta C, Chanona J et al: Is digitalis compound-induced cardiotoxicity, mediated through guinea-pig cardiomyocytes apoptosis? Eur J Pharmacol 2007, 566(1-3):34-42. [PubMed]
107. Padilla C, Hernández A, Sobrino S, Alonso O, Sánchez del Monte J, Maldonado V, Meléndez-Zajgla J: TNF alfa como marcador tumoral en cáncer gástrico. Endoscopia 2007, 19(4):241-247.
108. Montesinos M, Hernández A, Sobrino S, Alonso O, Meléndez-Zajgla J, Maldonado V, Tenorio T, Aviles A: Angiogénesis temprana inducida por oxigenación hiperbárica como predictor de respuesta clínica en pacientes con proctopatía por radiación. Endoscopia 2007, 19(4):352-357.
109. Melendez-Zajgla J, Maldonado V: A modified method for cloning adherent mammalian cells. Bioquimia 2007, 32(2):70-72.
110. Melendez-Zajgla J, Maldonado V: Is cancer a transmittable disease? Gaceta Medica De Mexico 2007, 143(4):353-354. [PubMed]
111. Martinez-Velazquez M, Melendez-Zajgla J, Maldonado V: Apoptosis induced by cAMP requires Smac/DIABLO transcriptional upregulation. Cell Signal 2007, 19(6):1212-1220. [PubMed]
112. Ceballos-Cancino G, Espinosa M, Maldonado V, Melendez-Zajgla J: Regulation of mitochondrial Smac/DIABLO-selective release by survivin. Oncogene 2007, 26(54):7569-7575. [PubMed]
113. Ramirez-Ortega M, Maldonado-Lagunas V, Melendez-Zajgla J, Carrillo-Hernandez JF, Pastelin-Hernandez G, Picazo-Picazo O, Ceballos-Reyes G: Proliferation and apoptosis of HeLa cells induced by in vitro stimulation with digitalis. Eur J Pharmacol 2006, 534(1-3):71-76. [PubMed]
114. Pruefer FG, Unger-Saldana K, Mohamier L, Ramirez M, Suarez J, Ramirez MT, Maldonado V, Melendez-Zajgla J: Tumor HGF lacks prognostic significance in Mexican breast cancer patients. J Exp Clin Cancer Res 2006, 25(3):357-364. [PubMed]
115. Mendoza J, Zamora R, Gallardo JC, Ceballos G, Aldana A, Espinosa M, Maldonado V, Melendez-Zajgla J: NF-kappaB does not influence the induction of apoptosis by Ukrain. Cancer Biol Ther 2006, 5(7):788-793. [PubMed]
116. Martinez-Velazquez M, Maldonado V, Ortega A, Melendez-Zajgla J, Albores A: Benzene metabolites induce apoptosis in lymphocytes. Exp Toxicol Pathol 2006, 58(1):65-70. [PubMed]
117. Gallardo Pérez J, Espinosa Castilla M, Meléndez Zajgla J, Maldonado V: Esferoides tumorales multicelulares en la evaluación de estrategias terapéuticas anticancerosas. Revista de Educación Bioquímica 2006, 25(4):101-107.
118. Espinosa M, Cantu D, Herrera N, Lopez CM, De la Garza JG, Maldonado V, Melendez-Zajgla J: Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer 2006, 6:45. [PubMed]
119. Ayala G, Torres L, Espinosa M, Fierros-Zarate G, Maldonado V, Melendez-Zajgla J: External membrane vesicles from Helicobacter pylori induce apoptosis in gastric epithelial cells. FEMS Microbiol Lett 2006, 260(2):178-185. [PubMed]
120. Arellano-Llamas A, Garcia FJ, Perez D, Cantu D, Espinosa M, De la Garza JG, Maldonado V, Melendez-Zajgla J: High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. BMC Cancer 2006, 6:256. [PubMed]
121. Lizarraga F, Espinosa M, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteinases-4 is expressed in cervical cancer patients. Anticancer Res 2005, 25(1b):623-627. [PubMed]
122. Espinosa M, Martinez M, Aguilar JL, Mota A, De la Garza JG, Maldonado V, Melendez-Zajgla J: Oxaliplatin activity in head and neck cancer cell lines. Cancer Chemother Pharmacol 2005, 55(3):301-305. [PubMed]
123. Martinez M, Moran J, Maldonado V, Melendez-Zajgla J: Smac/DIABLO y su papel en apoptosis. . Revista de Educación Bioquímica 2004, 23(2):64-70.
124. Lizarraga F, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteinases-2 growth-stimulatory activity is mediated by nuclear factor-kappa B in A549 lung epithelial cells. Int J Biochem Cell Biol 2004, 36(8):1655-1663. [PubMed]
125. Espinosa M, Cantu D, Lopez CM, De la Garza JG, Maldonado VA, Melendez-Zajgla J: SMAC is expressed de novo in a subset of cervical cancer tumors. BMC Cancer 2004, 4:84. [PubMed]
126. Montero O, Salle MT, Guevara R, Olivera P, Maldonado V, Melendez-Zajgla J: Cytogenetic analysis of the mononuclear cell component of giant cell tumors of bone. Cancer Genet Cytogenet 2003, 146(2):170-172. [PubMed]
127. Elinos-Baez CM, Maldonado V, Melendez-Zajgla J: [Caspases: apoptosis inducing molecules]. Gac Med Mex 2003, 139(5):493-499. [PubMed]
128. Ramirez Ortega Mdel C, Maldonado Lagunas V, Melendez Zajgla J, Zarco Olvera G, Avila Casados Mdel C, Suarez Munguia J, Pastelin Hernandez G: [Mechanism of cellular toxicity induced by digitalis compounds. Study with ouabain]. Arch Cardiol Mex 2002, 72 Suppl 1:S171-176. [PubMed]
129. Olivera P, Perez E, Ortega A, Terual R, Gomes C, Moreno LF, Duenas A, De La Garza J, Melendez-Zajgla J, Maldonado V: Estrogen receptor expression in giant cell tumors of the bone. Hum Pathol 2002, 33(2):165-169. [PubMed]
130. Lopez L, Villavicencio MA, Albores A, Martinez M, de la Garza J, Melendez-Zajgla J, Maldonado V: Cupressus lusitanica (Cupressaceae) leaf extract induces apoptosis in cancer cells. J Ethnopharmacol 2002, 80(2-3):115-120. [PubMed]
131. Hernandez P, Olivera P, Duenas-Gonzalez A, Perez-Pastenes MA, Zarate A, Maldonado V, Melendez-Zajgla J: Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 2001, 48(6):488-492. [PubMed]
132. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez A, Reyes M, Mota A, Munoz D, Solorza G, Hinojosa LM, Guadarrama R, Florentino R et al: A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 2001, 12(4):541-547. [PubMed]
133. Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J: Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 2001, 62(1):13-19. [PubMed]
134. Vazquez de Lara L, Becerril C, Montano M, Ramos C, Maldonado V, Melendez J, Phelps DS, Pardo A, Selman M: Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol Lung Cell Mol Physiol 2000, 279(5):L950-957. [PubMed]
135. Melendez J, Maldonado V, Bingle CD, Selman M, Pardo A: Cloning and expression of guinea pig TIMP-2. Expression in normal and hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 2000, 278(4):L737-743. [PubMed]
136. De Lara LV, Becerril C, Montano M, Ramos C, Maldonado V, Melendez J, Phelps DS, Pardo A, Selman M: Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. American Journal of Physiology-Lung Cellular and Molecular Physiology 2000, 279(5):L950-L957. [PubMed]
137. Melendez-Zajgla J, Cruz E, Maldonado V, Espinoza AM: Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin. Biochem Mol Biol Int 1999, 47(5):765-771. [PubMed]
138. Velazquez M, Maldonado V, Melendez-Zajgla J: Cisplatin-induced apoptosis of HeLa cells. Effect of RNA and protein synthesis inhibitors, Ca2+ chelators and zinc. J Exp Clin Cancer Res 1998, 17(3):277-284. [PubMed]
139. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, Segura-Valdez L, Sznajder JI, Selman M: Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 1998, 153(3):833-844. [PubMed]
140. Melendez Zajgla J, Maldonado Lagunas V: Cisplatino. Avances recientes en su mecanismo de acción. Revista del Instituto Nacional de Cancerologia 1998, 44(1):28-34.
141. Melendez-Zajgla J, Garcia C, Maldonado V: Subcellular redistribution of HSP72 protein during cisplatin-induced apoptosis in HeLa cells. Biochem Mol Biol Int 1996, 40(2):253-261. [PubMed]
142. Melendez J, Maldonado V, Ortega A: Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. Neurochem Res 1996, 21(6):653-658. [PubMed]
143. Maldonado V, De Anda J, Melendez-Zajgla J: Paclitaxel-induced apoptosis in HeLa cells is serum dependent. J Biochem Toxicol 1996, 11(4):183-188. [PubMed]
144. Maldonado V, Melendez J, Gonzalez H, Ortega A: Internucleosomal DNA cleavage in HeLa cells exposed to cisplatin. Biochem Mol Biol Int 1995, 37(4):691-696. [PubMed]
145. Maldonado V, Chan L, Melendez J, Rincon AR, Zhu HJ, Panduro A: Regulation of apo B mRNA expression in liver and intestine during liver regeneration induced by CCl4. Biochim Biophys Acta 1994, 1211(1):1-6. [PubMed]
146. Panduro A, Morales L, Santos A, Valdes L, Lima G, Melendez J, Cabrera G, Maldonado V, Villalobos JJ: [New strategies in the clinical evaluation of patients with colon cancer based on molecular studies]. Rev Gastroenterol Mex 1993, 58(2):119-127. [PubMed]
147. Panduro A, Lima G, Meléndez J, Cabrera G, Del Bosque L, Morales L, Santos J, Villalobos J: Estudios moleculares del cáncerde colon en el Instituto Nacional de la Nutrición Salvador Zubirán. Revista de la Facultad de Medicina 1993, 36:1.
More papers
- Padilla C, Hernández A, Sobrino S, Alonso O, Sánchez del Monte J, Maldonado V, Meléndez-Zajgla J: TNF alfa como marcador tumoral en cáncer gástrico. Endoscopia 2007, 19(4):241-247.
- Ceballos-Cancino G, Melendez-Zajgla J: DIABLO (diablo, IAP-binding mitochondrial protein). . Atlas Genet Cytogenet Oncol Haematol 2013(http://AtlasGeneticsOncology.org/Genes/DIABLOID42995ch12q24.html).
- Gallardo Pérez J, Espinosa Castilla M, Meléndez Zajgla J, Maldonado V: Esferoides tumorales multicelulares en la evalua-ción de estrategias terapéuticas anticancerosas. . Revista de Educación Bioquímica 2006, 25(4):101-107.
- Montesinos M, Hernández A, Sobrino S, Alonso O, Meléndez-Zajgla J, Maldonado V, Tenorio T, Aviles A: Angiogénesis temprana inducida por oxigenación hiperbárica como predictor de respuesta clínica en pacientes con proctopatía por radiación. Endoscopia 2007, 19(4):352-357.
- Martinez M, Moran J, Maldonado V, Melendez-Zajgla J: Smac/DIABLO y su papel en apoptosis. . Revista de Educación Bioquímica 2004, 23(2):64-70.
- Meléndez-Zajgla J, G C-C: Sobreviviendo a diablo: lecciones de la survivina en la apoptosis Mensaje Bioquímico 2008, 32:175-184.
- Melendez-Zajgla J, Maldonado V: A modified method for cloning adherent mammalian cells. . Bioquimia 2007, 32(2):70-72.
- Panduro A, Morales L, Santos A, Valdes L, Lima G, Melendez J, Cabrera G, Maldonado V, Villalobos JJ: New strategies in the clinical evaluation of patients with colon cancer based on molecular studies. Revista de gastroenterologia de Mexico 1993, 58(2):119-127.
- Ramirez Ortega MdC, Maldonado Lagunas V, Melendez Zajgla J, Zarco Olvera G, Avila Casados MDC, Suarez Munguia J, Pastelin Hernandez G: Mechanism of cellular toxicity induced by digitalis compounds. Study with ouabain. Archivos de cardiologia de Mexico 2002, 72 Suppl 1:S171-176.
- Melendez Zajgla J, Maldonado Lagunas V: Cisplatino. Avances recientes en su mecanismo de acción. Revista del Instituto Nacional de Cancerologia 1998, 44(1):28-34.
- Panduro A, Lima G, Meléndez J, Cabrera G, Del Bosque L, Morales L, Santos J, Villalobos J: Estudios moleculares del cáncerde colon en el Instituto Nacional de la Nutrición Salvador Zubirán. Revista de la Facultad de Medicina 1993, 36:1.
Science Divulgation
- Células troncales: ¿Clave para curar el Cáncer?. Jorge Meléndez Zajgla y Vilma Maldonado Lagunas. Ciencia y Desarrollo. Octubre del 2008.
- El lado amable de DIABLO. Jorge Meléndez Zajgla. Gaceta Biomédicas. Noviembre del 2007.
- El Instituto Nacional de Medicina Genómica. Vocación y Retos. Soberón-Mainero X, Meléndez-Zajgla, J. Revista de Investigación Clínica. 2010: 62, 391-392
Melendez-Zajgla Lab 